Acute Myeloid Leukemia (AML): Treatment Options After Relapse

×
NOW
PLAYING
For AML Relapse: The Role of IDH-Inhibitor Drugs To Achieve Remission For Stem-Cell Transplant
NOW
PLAYING
Symptoms of Relapse in Acute Myeloid Leukemia (AML)
NOW
PLAYING
What is The Treatment For Acute Myeloid Leukemia (AML) Patients After Relapse: Gilteritinib And FLT3 Inhibitors
NOW
PLAYING
What Are The Options For Patients When Acute Myeloid Leukemia Returns?

Relapse : Symptoms & Diagnosis

SEE MORE   

  • Relapse is a part of the journey for many AML patients
  • The timing of relapse will be a big part of making treatment decisions
  • Monitoring health after initial treatment is crucial for people with AML

Relapse : Symptoms & Diagnosis

  • Relapse is a part of the journey for many AML patients
  • The timing of relapse will be a big part of making treatment decisions
  • Monitoring health after initial treatment is crucial for people with AML

Relapse : Exploring the Options

SEE MORE   

  • Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
  • Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease

Relapse : Exploring the Options

  • Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
  • Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.